# Carter Williams

> Carter Williams is a Series B investor at iSelect Fund backing Biotechnology and SaaS. See 9 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [iSelect Fund](https://shizune.co/investors/profile/iselectfund)
- Location: Saint Louis, United States
- Total investments: 9
- Last investment: Aug 2025
- Lead investor: 22%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/in/carter
- X (Twitter): http://twitter.com/oiventures
- Website: http://iselectfund.com
- Facebook: http://www.facebook.com/jcarterwil

Carter Williams is a Series B investor at iSelect Fund in Saint Louis focused on Biotechnology and SaaS. Carter Williams is the CEO if iSelect Fund.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 44% |
| SaaS | 2 | 22% |
| AgTech | 2 | 22% |
| Software | 2 | 22% |
| Agriculture | 2 | 22% |

20 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 22% |
| Funding Round | 2 | 22% |
| Seed | 1 | 11% |
| Series A | 1 | 11% |
| Series C | 1 | 11% |

7 stages tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Geltor | Biodesigned proteins for beauty, wellness and beyond. |  | Venture - Series Unknown | Aug 07, 2025 |  |
| ImmunoPhotonics | ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a strategic partnership with Veterinary Cancer Therapeutics, LLC. The company was founded in 2008 and is based in Columbia, Missouri. | $21.4M | Series B | Apr 06, 2022 |  |
| Artemis | Artemis operates an intelligence platform for indoor farms. It specializes in indoor farming software solutions. Artemis help indoor farm operators use data to make more profitable production decisions. It tracks and analyzes all farm data in one place, enabling growers to optimize plant performance and reduce operating expenses.Allison Kopfand Jason Camp founded Agrilyst in 2015 that later became Artemis. It has its headquarters in Brooklyn in New York City. | $8M | Series A | May 20, 2019 |  |
| Benson Hill | Benson Hill is a crop improvement company that unlocks the natural diversity of plants and empowers innovators with a revolutionary crop design platform to develop healthier and more sustainable food and ingredients.Benson Hill empowers innovators to develop more healthy, flavorful, and sustainable food by unlocking the natural genetic diversityof plants. Benson Hill’s CropOS™ platform combines machine learning and big data with breeding techniques and plant biology to drastically accelerate and simplify the product development process. | $65M | Series C | Sep 10, 2018 |  |
| Artemis | Artemis operates an intelligence platform for indoor farms. It specializes in indoor farming software solutions. Artemis help indoor farm operators use data to make more profitable production decisions. It tracks and analyzes all farm data in one place, enabling growers to optimize plant performance and reduce operating expenses.Allison Kopfand Jason Camp founded Agrilyst in 2015 that later became Artemis. It has its headquarters in Brooklyn in New York City. | $1.5M | Corporate Round | Jan 31, 2018 |  |
| Benson Hill | Benson Hill is a crop improvement company that unlocks the natural diversity of plants and empowers innovators with a revolutionary crop design platform to develop healthier and more sustainable food and ingredients.Benson Hill empowers innovators to develop more healthy, flavorful, and sustainable food by unlocking the natural genetic diversityof plants. Benson Hill’s CropOS™ platform combines machine learning and big data with breeding techniques and plant biology to drastically accelerate and simplify the product development process. | $25M | Series B | May 28, 2017 |  |
| Euclises Pharmaceuticals | Euclises Pharmaceuticals, Inc is developing novel pain and cancer medications that offer superior safety margins compared to existing drugs. The company is based on new inventions from Dr. John Talley, the most accomplished medicinal chemist in the world. Dr. Talley previously invented Celebrex and seven other approved drugs. New compounds fromEuclises will offer both improved efficacy and safety relative to existing therapies. Euclises is located at the BioGenerator Accelerator Labs. | $1.2M |  | Dec 01, 2016 |  |
| StreamLink Software | StreamLink Software-is a Software-as-a-Service company that develops grant management software for nonprofits and the public sector. Ther grants management solution, AmpliFund, is designed for managing every stage of the grant lifecycle and is at the forefront of automating grant compliance and data standardization in the public sector.It wasfounded in 2008 and is headquartered in Cleveland, Ohio. | $10M |  | Jun 10, 2016 |  |
| Open Studio Network | Open Studio Network Access to premier musical artists, through a simple, interactive online lesson platform. |  | Seed | Dec 01, 2015 |  |

9 of 9 investments shown.

## Co-investors
- [Argonautic Ventures](https://shizune.co/investors/profile/argonautic-ventures) — VC Fund, 3 deals together
- [Fall Line Capital](https://shizune.co/investors/profile/fall-line-capital) — VC Fund, 2 deals together
- [Lewis & Clark Ventures](https://shizune.co/investors/profile/lewis---clark-ventures) — VC Fund, 2 deals together
- [Mercury Fund](https://shizune.co/investors/profile/mercury-fund) — VC Fund, 2 deals together
- [Prelude Ventures](https://shizune.co/investors/profile/prelude-ventures-llc) — VC Fund, 2 deals together
- [S2G Investments](https://shizune.co/investors/profile/s2g-ventures) — VC Fund, 2 deals together

## About iSelect Fund

VC Fund · St Louis, United States

From spiraling healthcare costs, to the rise of chronic diseases, to feeding a growing global population, the world is facing a complex web of interrelated challenges. iSelect was created to help solve these problems, connecting investors with the innovative companies that are fixing the food and health systems while opening up access to investmentopportunities that are making a real impact on the future of our world.

5 contacts available at iSelect Fund.

| Name | Title | Profile |
| --- | --- | --- |
| Ken Harrington | Selection Committee | https://shizune.co/investors/profile/ken-harrington |
| Bobby Sandage | Member of Selection Committee | https://shizune.co/investors/profile/bobby-w-sandage |
| Carter Williams | CEO and Managing Director | https://shizune.co/investors/profile/carter-williams |
| Craig Herron | Managing Director | https://shizune.co/investors/profile/craig-herron |
| Dan Schaub | COO | https://shizune.co/investors/profile/dan-schaub |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Carter Williams invest in?

Carter Williams invests primarily in Biotechnology, SaaS and AgTech startups, most often at Series B and Funding Round stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Carter Williams last invest?

The most recent investment recorded for Carter Williams closed in Aug 2025. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co